MedinCell S.A. (EPA:MEDCL)

MedinCell Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	450	276	246	186	288	120
Market Cap Growth	148.22%	11.97%	32.11%	-35.19%	140.10%	-4.59%
Enterprise Value	480	315	281	195	304	137
Last Close Price	13.60	9.59	9.81	7.42	11.70	5.96
Forward PE	61.82	-	-	6.91	-	-
PS Ratio	29.92	23.08	18.03	22.35	35.13	19.96
PB Ratio	-8.44	-6.75	-5.82	-13.94	31.51	-7.51
P/TBV Ratio	-	-	-	-	37.64	-
EV/Sales Ratio	36.36	26.37	20.55	23.37	37.15	22.78
Debt / Equity Ratio	-1.28	-1.58	-1.36	-3.55	4.75	-2.12
Asset Turnover	0.24	0.36	0.37	0.15	0.18	0.18
Quick Ratio	1.41	1.59	0.33	0.84	4.01	2.54
Current Ratio	1.46	1.66	0.34	0.89	4.14	2.69
Return on Assets (ROA)	-22.38%	-39.49%	-40.78%	-27.58%	-26.02%	-36.71%
Return on Capital (ROIC)	-44.12%	-66.61%	-60.63%	-34.37%	-33.63%	-46.85%
Earnings Yield	-7.00%	-9.08%	-13.00%	-13.31%	-6.60%	-19.97%
FCF Yield	4.68%	-4.44%	-8.76%	-12.33%	-4.44%	-10.95%
Buyback Yield / Dilution	-9.39%	-12.83%	-1.39%	-12.79%	-9.52%	-16.53%
Total Shareholder Return	-9.39%	-12.83%	-1.39%	-12.79%	-9.52%	-16.53%

Source: S&P Capital IQ. Standard template. Financial Sources.